Tarsus Pharmaceuticals (TARS) Short-term Investments (2019 - 2025)

Tarsus Pharmaceuticals' Short-term Investments history runs 7 years deep, the most recent figure standing at $233.6 million for Q4 2025.

• In Q4 2025, Short-term Investments changed N/A year-over-year to $233.6 million; the TTM figure through Dec 2025 stood at $233.6 million (changed N/A YoY), while the FY2025 annual figure was $233.6 million, changed N/A from the prior year.
• Short-term Investments was $233.6 million for Q4 2025 at Tarsus Pharmaceuticals, down from $289.1 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $289.1 million in Q3 2025 to a low of $20000.0 in Q1 2021.
• Historically, Short-term Investments has averaged $116.3 million across 5 years, with a median of $120.0 million in 2023.
• Biggest YoY gain for Short-term Investments was 46368.04% in 2023; the steepest drop was 98.28% in 2023.
• A 5-year view of Short-term Investments shows it stood at $483000.0 in 2021, then surged by 29996.48% to $145.4 million in 2022, then tumbled by 98.28% to $2.5 million in 2023, then surged by 5540.96% to $140.7 million in 2024, then soared by 66.0% to $233.6 million in 2025.
• The last three Short-term Investments figures came in at $233.6 million (Q4 2025), $289.1 million (Q3 2025), and $284.5 million (Q2 2025), per Business Quant data.